A multicentre study to introduce naltrexone for opiate dependence in Spain

Area of Science:

• Pharmacology
• Addiction Medicine
• Clinical Research

Background:

• Opiate dependence and abuse pose significant public health challenges.
• Effective, long-term treatment options for opiate users are crucial.
• Naltrexone is an opioid antagonist with potential therapeutic applications.

Purpose of the Study:

• To evaluate the clinical utility of naltrexone in treating opiate dependents and abusers.
• To assess the retention rate as a primary outcome measure for naltrexone therapy.
• To document adverse effects associated with naltrexone in this population.

Main Methods:

• A multicentre prospective study conducted across eight Spanish centers.
• Inclusion of 113 opiate dependents and 37 opiate abusers, without selection bias.
• Evaluation focused on patient retention rates at six months.

Main Results:

• Achieved a 40% retention rate at six months, exceeding previous reports for non-selected patients.
• Observed mild adverse effects that did not result in treatment discontinuation.
• Suggests potential contribution of non-pharmacological factors to treatment success.

Conclusions:

• Naltrexone demonstrates promising effectiveness in retaining opiate-dependent individuals in treatment.
• The treatment is generally well-tolerated with manageable side effects.
• Further research into combined pharmacological and non-pharmacological interventions is warranted.